Related Experiment Video
Updated: Apr 7, 2026
08:14
Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia
Published on: July 25, 2017
16.0K
Tumorigenesis: it takes a village
Doris P Tabassum1, Kornelia Polyak2
11] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. [2] BBS Program, Harvard Medical School, Boston, Massachusetts 02115, USA.
Nature Reviews. Cancer
|July 10, 2015
Summary
Cancer cells within tumors cooperate, influencing disease progression and complicating treatments. Understanding these subclone interactions is key to developing effective cancer therapies.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment
Background:
- Intratumor heterogeneity is a hallmark of cancer, yet the dynamics among tumor subpopulations remain poorly understood.
- Emerging evidence suggests cancer cells interact cooperatively, forming communities that impact disease progression.
- These complex subclonal interactions present significant challenges for cancer treatment.
Purpose of the Study:
- To review current research on cooperative behaviors among cancer subclones.
- To highlight the influence of these interactions on tumor progression and therapeutic resistance.
- To propose novel therapeutic strategies that address tumor heterogeneity and subclone cooperation.
Main Methods:
- Literature review of studies investigating cancer cell interactions.
- Analysis of cooperative dynamics within heterogeneous tumors.
- Synthesis of findings to inform therapeutic development.
Main Results:
- Demonstrated cooperative interactions among cancer subclones in various tumor types.
- Highlighted how these interactions contribute to therapeutic challenges and poor patient prognosis.
- Identified specific examples of subclone cooperation influencing disease progression.
Conclusions:
- Understanding cooperative subclonal dynamics is crucial for advancing cancer treatment.
- Novel therapeutic strategies must account for tumor heterogeneity and cell-cell cooperation.
- Targeting these interactions offers a promising avenue for improving cancer patient outcomes.
More Related Videos
Related Concept Videos
02:07Tumor Progression
3.6K
3.6K
02:07Tumor Progression
7.9K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.9K
01:25Mutagenicity and Carcinogenicity
2.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.2K
02:21Cancers Originate from Somatic Mutations in a Single Cell
15.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.5K
02:21Cancers Originate from Somatic Mutations in a Single Cell
3.5K
3.5K
01:33Cancer-Critical Genes I: Proto-oncogenes
12.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
12.0K